Cargando…
Infant cholestasis patient with a novel missense mutation in the AKR1D1 gene successfully treated by early adequate supplementation with chenodeoxycholic acid: A case report and review of the literature
Steroid 5β-reductase [aldo-keto reductase family 1 member D1 (AKR1D1)] is essential for bile acid biosynthesis. Bile acid deficiency caused by genetic defects in AKR1D1 leads to life-threatening neonatal hepatitis and cholestasis. There is still limited experience regarding the treatment of this dis...
Autores principales: | Wang, Hui-Hui, Wen, Fei-Qiu, Dai, Dong-Ling, Wang, Jian-She, Zhao, Jing, Setchell, Kenneth DR, Shi, Li-Na, Zhou, Shao-Ming, Liu, Si-Xi, Yang, Qing-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148433/ https://www.ncbi.nlm.nih.gov/pubmed/30254413 http://dx.doi.org/10.3748/wjg.v24.i35.4086 |
Ejemplares similares
-
Successful treatment of infantile oxysterol 7α-hydroxylase deficiency with oral chenodeoxycholic acid
por: Tang, Yun-Ping, et al.
Publicado: (2021) -
Case Report: Early Treatment With Chenodeoxycholic Acid in Cerebrotendinous Xanthomatosis Presenting as Neonatal Cholestasis
por: Degrassi, Irene, et al.
Publicado: (2020) -
Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment
por: Huidekoper, Hidde H., et al.
Publicado: (2015) -
A combination of mutations in AKR1D1 and SKIV2L in a family with severe infantile liver disease
por: Morgan, Neil V, et al.
Publicado: (2013) -
Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)